The Society for Immunotherapy of Cancer (SITC) is excited to announce Susan Kaech, PhD, from Salk Institute as the Keynote Speaker at its 38th Annual Meeting and Pre-Conference Programs. The title of her presentation is "Stressing Out the Immune System in Cancer." SITC is also hosting Robert D. Schreiber, PhD, FAIO, Washington School of Medicine, the 2023 recipient of the Richard V. Smalley Memorial Award and Lectureship, the society's most prestigious award and which honors those who have been pioneers in their work and made a notable impact on the field of cancer immunotherapy. Dr. Schreiber will also give a presentation as a part of this award.
MILWAUKEE, May 11, 2023 /PRNewswire-PRWeb/ -- The Society for Immunotherapy of Cancer (SITC) is excited to announce Susan Kaech, PhD, from Salk Institute as the Keynote Speaker at its 38th Annual Meeting and Pre-Conference Programs. The title of her presentation is "Stressing Out the Immune System in Cancer." SITC is also hosting Robert D. Schreiber, PhD, FAIO, Washington School of Medicine, the 2023 recipient of the Richard V. Smalley Memorial Award and Lectureship, the society's most prestigious award and which honors those who have been pioneers in their work and made a notable impact on the field of cancer immunotherapy. Dr. Schreiber will also give a presentation as a part of this award.
"SITC is proud to continue to bring together the best and brightest minds in cancer immunotherapy to further the science and educate the next generation of scientists and clinicians," said SITC President Leisha Emens, MD, PhD. "The incredible opportunity for networking with such a diverse audience from so many disciplines really makes this a special event."
As the largest conference focused solely on cancer immunotherapy, SITC 2023 will feature cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. The meeting also includes updates on major national and international initiatives coming from academia, government and industry.
"We have put together a tremendous line-up of immune-oncology expert speakers presenting the cutting-edge science that is moving our field forward," said E. John Wherry, PhD, 2023 SITC Annual Program Committee Chair. "It remains a catalytic time for cancer immunology and immunotherapy and the new science and exciting interactions and collaborations that are emblematic of SITC meetings will ultimately help attendees bring novel treatments for patients dealing with cancer."
You can register now for the SITC's 38th Annual Meeting & Pre-Conference Programs (SITC 2023), being held from Nov. 1–5, 2023, at the San Diego Convention Center in San Diego, CA. Virtual participation is also available. Visit http://www.sitcancer.org for more information on this event and other SITC resources.
SITC 2023 attendees will:
- Participate in key scientific sessions focused on a variety of basic-, translational- and clinical-focused topics from leaders in the field
- Learn about cutting-edge research via oral abstract presentations and poster presentations – the 37th Annual Meeting had over 1,500 abstract submissions
- Engage with industry representatives and learn about the latest technological advances in our exhibit hall
- Earn continuing education credits
- Connect with other SITC 2023 attendees from around the world
Registration is now underway for SITC 2023, taking place Nov. 1–5, 2023. Click here to register, view sessions, learn about advertising and sponsorship opportunities and more. In addition, SITC is now accepting submissions for Regular and Young Investigator Award Abstracts. The deadline for submissions is June 27, 2023 and can be submitted here.
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word "cure" a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.
Media Contact
Thomas Martin, Society for Immunotherapy of Cancer, 414.271.2456, [email protected]
SOURCE Society for Immunotherapy of Cancer
Share this article